Thauvin-Robinet-Faivre Syndrome: A FIBP Variant in an Adolescent with Segmental Overgrowth and Thyroid Carcinoma

Ülkü Gül Şıraz, D. Göl, Meino Rohlfs, Christoph Klein, Ekrem Ünal, Nihal HatipogluJournal of Clinical Research in Pediatric Endocrinology 2025 · DOI

Introduction

Overgrowth syndromes represent a rare and heterogeneous group of genetic disorders characterized by excessive prenatal or postnatal growth. These conditions can manifest as generalized macrosomia or segmental overgrowth, where specific body regions develop disproportionately. Often, these syndromes are linked to dysregulation in growth factor signaling pathways, such as the PI3K/AKT/mTOR pathway, which inherently increases the risk of malignancy.

Thauvin-Robinet-Faivre Syndrome (TROFAS) is an exceptionally rare autosomal recessive overgrowth disorder caused by biallelic variants in the FIBP (FGF-1 intracellular binding protein) gene. Prior to this report, only eight cases had been documented globally. This case details the ninth known instance, identifying unique clinical features and significantly expanding the known oncological spectrum of the disease.

Case Presentation and Clinical Profile

The patient, a 16-year-old female, presented with a complex clinical phenotype. Notably, she did not exhibit the generalized macrosomia or tall stature seen in some other TROFAS cases, underscoring the variability of the syndrome. Instead, her presentation was dominated by segmental anomalies and intellectual disability (IQ 65).

Physical examination revealed distinctive facial dysmorphism, including a flat midface, thick lips, and synophrys. Skeletal abnormalities such as pectus excavatum and scoliosis were also present. Most strikingly, the patient exhibited significant segmental overgrowth of the hands and feet, as illustrated in the clinical photography.

Figure 5: Comparison of the patient's hands, demonstrating significant segmental overgrowth and asymmetry.

Further clinical investigation identified extensive vascular involvement, including varicose veins and port-wine stains. Skin examination also revealed nodules on the extremities, further characterizing the segmental nature of the disorder.

Figure 6: Segmental overgrowth of the hand and forearm, accompanied by skin nodules and vascular discoloration.

Genomic and Pathological Findings

Whole Exome Sequencing (WES) performed on the patient and her father identified a homozygous, likely pathogenic frameshift variant in the FIBP gene: NM_004214.5 c.412-3_415dup (p.Asp139AlafsTer3). This variant likely results in a truncated, non-functional protein.

The FIBP gene product interacts with Fibroblast Growth Factors (FGFs), which are critical for cell proliferation and differentiation. The loss of functional FIBP protein is thought to dysregulate these processes, potentially through the mTOR/STAT3 pathways, providing a molecular link between the observed overgrowth and the patient's predisposition to cancer.

Oncological Significance

The most critical finding in this case is the early onset of multiple malignancies. By age 16, the patient developed both thyroid follicular carcinoma and parotid mucoepidermoid carcinoma. Previously, the only malignancy associated with TROFAS was a single reported case of Wilms' tumor. This case marks TROFAS as a condition requiring rigorous and early oncological screening, as it expands the known tumor predisposition spectrum to include head and neck carcinomas.

Discussion and Future Directions

This case highlights that TROFAS can present with normal overall height and weight while still exhibiting severe segmental overgrowth and life-threatening malignancies. The identification of thyroid and parotid carcinomas marks a significant shift in our understanding of the syndrome's risks.

Future research must focus on functional studies to elucidate the exact molecular mechanisms by which FIBP loss-of-function triggers specific cancers. Furthermore, establishing standardized clinical surveillance protocols is essential for the early detection of tumors in this vulnerable population. Given the rarity of the condition, exploring the possibility of mosaic FIBP variants in "unsolved" overgrowth cases may also yield further insights into the disease's prevalence and pathophysiology.

Summary updated

Abstract

Overgrowth syndromes are rare genetic disorders arising from alterations in the growth factors pathway. These syndromes can present as generalized overgrowth, characterized by macrosomia and excessive height compared to peers, or partial overgrowth syndromes, where specific body regions exhibit disproportionate growth often accompanied by vascular anomalies. Both forms are associated with an increased risk of tumor development. The FGF-1 intracellular binding protein (FIBP) gene plays a critical role in cell proliferation and differentiation by interacting with growth factors. In this article, we present a case of Thauvin-Robinet-Faivre Syndrome (TROFAS) in a 16-year-old girl, diagnosed with homozygous NM_004214.5 c.412-3_415dup (p.Asp139AIafsTer3) variant in the FIBP gene. This case exhibits phenotypic features and tumor development, including thyroid follicular carcinoma and parotid mucoepidermoid carcinoma, that have not been previously reported in association with this syndrome. Recent studies have implicated FIBP gene defects in overgrowth syndromes, with only a limited number of cases described globally. Our case expands the known clinical and tumor spectrum associated with TROFAS, providing new insights into the pathophysiology of this rare disorder.
BibTeX
@article{sraz2025thauvin,
  author = {Ülkü Gül Şıraz and D. Göl and Meino Rohlfs and Christoph Klein and Ekrem Ünal and Nihal Hatipoglu},
  title = {{Thauvin-Robinet-Faivre Syndrome: A FIBP Variant in an Adolescent with Segmental Overgrowth and Thyroid Carcinoma}},
  journal = {Journal of Clinical Research in Pediatric Endocrinology},
  year = {2025},
  doi = {10.4274/jcrpe.galenos.2025.2024-10-12},
}
Figure